Xact Kapitalforvaltning’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Xact Kapitalforvaltning’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$375K	Hold	8,930	–	–	0.01%	891
2019 Q4	$406K	Hold	8,930	–	–	0.01%	1094
2019 Q3	$409K	Hold	8,930	–	–	0.01%	1031
2019 Q2	$524K	Hold	8,930	–	–	0.01%	891
2019 Q1	$400K	Hold	8,930	–	–	0.01%	1058
2018 Q4	$348K	Buy	8,930 +1,600	+22%	+$62.8K	0.01%	1139
2018 Q3	$337K	Hold	7,330	–	–	0.01%	1281
2018 Q2	$320K	Buy	7,330 +1,000	+16%	+$43K	0.01%	1304
2018 Q1	$250K	Buy	+6,330	New	+$246K	0.01%	1362

Other funds holding ARNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Xact Kapitalforvaltning's ARNA Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Arena Pharmaceuticals Inc (ARNA) position steady in Q1 2020 at 8,930 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #891.

Xact Kapitalforvaltning first reported a position in ARNA in Q1 2018 and has held it in 9 quarters since. The position peaked at $524K in Q2 2019. 219 funds tracked by Wall St. Rank hold ARNA as of Q1 2020.

Xact Kapitalforvaltning held 8,930 shares of Arena Pharmaceuticals Inc worth $375K as of Q1 2020.
Xact Kapitalforvaltning left its Arena Pharmaceuticals Inc share count unchanged in Q1 2020.
Arena Pharmaceuticals Inc made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #891 holding.
Xact Kapitalforvaltning first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and has held it in 9 quarters since.
Xact Kapitalforvaltning's Arena Pharmaceuticals Inc position peaked at $524K in Q2 2019.
219 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.